price
AM
NASDAQ · AMRX
Amneal Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$16.65
Up+$1.43 (+8.59%)
Updated Sep 16, 2026, 9:45 PM
SID Score
5.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.34B
- P/E ratio
- 60.06
- Dividend yield
- 0.00%
- 52-week range
- $11.71 – $19.26
- Volume
- 1.79M
- Avg. volume
- 2.49M
Price performance
AMRX price history
1M range · 20 trading sessions · Daily adjusted prices
AMRX closed at $16.65 after 20 trading sessions, down 8.47% for the selected period.
- Last close
- $16.65
- Period change
- -8.47%
- Period low
- $16.65
- Period high
- $18.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $17.22 | $17.25 | $16.58 | $16.65 | 1.79M |
| Sep 14, 2026 | $17.11 | $17.30 | $16.98 | $17.22 | 1.6M |
| Sep 11, 2026 | $17.00 | $17.11 | $16.73 | $17.01 | 1.16M |
| Sep 10, 2026 | $17.22 | $17.3094 | $16.825 | $16.87 | 1.04M |
| Sep 9, 2026 | $17.27 | $17.36 | $17.08 | $17.25 | 1.47M |
| Sep 8, 2026 | $17.27 | $17.395 | $16.98 | $17.05 | 2.04M |
| Sep 4, 2026 | $17.57 | $17.705 | $17.37 | $17.44 | 1.44M |
| Sep 3, 2026 | $18.25 | $18.26 | $17.735 | $17.87 | 2.75M |
| Sep 2, 2026 | $17.90 | $18.32 | $17.61 | $18.06 | 2.61M |
| Sep 1, 2026 | $17.57 | $17.99 | $17.40 | $17.68 | 1.36M |
| Aug 31, 2026 | $17.46 | $17.615 | $17.175 | $17.47 | 1.74M |
| Aug 28, 2026 | $18.04 | $18.10 | $17.47 | $17.54 | 1.15M |
| Aug 27, 2026 | $17.82 | $18.11 | $17.60 | $18.01 | 1.1M |
| Aug 26, 2026 | $18.00 | $18.12 | $17.85 | $17.99 | 1.21M |
| Aug 25, 2026 | $17.78 | $17.96 | $17.61 | $17.92 | 1.14M |
| Aug 24, 2026 | $17.81 | $17.92 | $17.6101 | $17.78 | 1.79M |
| Aug 21, 2026 | $17.99 | $18.12 | $17.77 | $17.91 | 1.37M |
| Aug 20, 2026 | $17.87 | $18.025 | $17.7338 | $17.90 | 1.25M |
| Aug 19, 2026 | $18.51 | $18.58 | $17.95 | $18.11 | 1.47M |
| Aug 18, 2026 | $18.45 | $18.76 | $18.02 | $18.19 | 2.03M |
Latest AMRX news
The latest Smart Investors Daily articles mentioning AMRX.
Stock researchResearch & News · Competitors
Loading stock research…